Compare CYD & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYD | OMCL |
|---|---|---|
| Founded | 1951 | 1992 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Computer Manufacturing |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 1998 | 2000 |
| Metric | CYD | OMCL |
|---|---|---|
| Price | $44.26 | $40.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $60.00 | $51.14 |
| AVG Volume (30 Days) | 240.5K | ★ 847.7K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $15.94 | $6.77 |
| Revenue Next Year | $7.89 | $4.82 |
| P/E Ratio | ★ $32.71 | $1,030.38 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $12.66 | $22.66 |
| 52 Week High | $56.55 | $51.84 |
| Indicator | CYD | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 45.79 |
| Support Level | $34.58 | $29.19 |
| Resistance Level | $45.93 | $45.36 |
| Average True Range (ATR) | 3.17 | 1.51 |
| MACD | -1.29 | 0.50 |
| Stochastic Oscillator | 7.07 | 72.52 |
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.